The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
The Food and Drug Administration granted approval Tuesday to a closely watched Alzheimer’s drug, concluding that the benefits ...
"Every step forward brings us a little bit closer to a world without Alzheimer's," said Beth Sulkowski, Alzheimer's ...
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second ...
Lilly’s drug that can slow Alzheimer’s disease has received the approval of the U.S. Food and Drug Administration; the ...
There’s no cure for Alzheimer’s disease, but in the past few years, researchers have found treatments that seem to stop some ...
The FDA has approved Eli Lilly's Alzheimer's drug that can slow memory decline. CONWAY GITTENS: I’m Conway Gittens reporting ...
Eli Lilly received FDA approval for a drug to help treat Alzheimer's on Tuesday after studies showed it could help slow the ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
The Food and Drug Administration on Tuesday approved the experimental Alzheimer's drug donanemab, which slowed the early stages of the fatal mind-robbing disease in studies. The approval comes ...
WASHINGTON — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory ...